# Cellares: Pharmaceuticals, South San Francisco, United States

> Cellares: Cellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated Development and...

Source: https://millionrounds.com/startup/cellares (Millionrounds; every figure on the page links to its filing or article)

United States · [Pharmaceuticals startup](https://millionrounds.com/companies)

# Cellares

Cellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated Development and Manufacturing Organization (IDMO).

Funding reported Last round: Series C

Pharmaceuticals South San Francisco, United States

Company summary

- **Founded:** 2019 7 years old
- **Team:** 280 201 to 1,000 people
- **Funding reported:** $355M in dollars
- **Last round:** Series C Aug 2023

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Cellares has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Cellares

Cellares is a biotechnology company based in South San Francisco, California, and is recognized as the world’s first Integrated Development and Manufacturing Organization (IDMO).

Founded in 2019, Cellares employs an Industry 4.0 approach to mass-manufacture living cell therapies using fully automated and scalable platforms. The company focuses on enabling drug sponsors to develop, scale, and commercialize cell therapies efficiently to meet global patient demand. Cellares offers end-to-end cell therapy development and manufacturing services, addressing production bottlenecks that can delay patient access to FDA-approved treatments. Key offerings include the Cell ShuttleTM, an automated platform for producing suspension-based cell therapies, and Cell QTM, a quality control system that ensures compliance and reproducibility. The company operates globally with purpose-built Smart Factories that significantly enhance throughput and reduce costs compared to traditional models. Cellares serves a range of B2B clients, including major pharmaceutical firms, biotechnology companies, and academic institutions, all seeking to scale their cell therapy production.

## What company datasets say Cellares raised

Funding, as reported

Reported in all **$355M** in dollars

Rounds **3**

Last round **Series C**

Last round size **$327M**

Last round date **Aug 2023**

Investors listed **9**

SEC Form D **$82M sold, 1 filing, last May 2021**

## Founders and team

From the SEC filings it signed: 2 founders.

**Fabian Gerlinghaus** Co-Founder & CEO, Cellares *Named on its 2021 Form D*

**Omar Kurdi** Co-Founder & President, Cellares *Named on its 2021 Form D*

On the board, as filed i *Justin Butler*

## On 5 portfolio pages

Investors who name them

- [VONROSEN](https://millionrounds.com/fund/vonrosen)
- [8VC](https://millionrounds.com/fund/8vc)
- [Decheng Capital](https://millionrounds.com/fund/decheng-capital)
- [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital)
- [Intuitive Ventures](https://millionrounds.com/fund/intuitive-ventures)

Each firm lists Cellares on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

## The company, in detail

What they build

Known for

health care cell therapy supply chain manufacturing scalability mass production biotech automation solutions bioprocessing equipment personalized cell therapy automated cell therapy process manufacturing medicine digital cell therapy factory cell therapy enterprises process scalability scalable bioprocessing solutions global manufacturing

Built with from their website

Microsoft Azure Monitor Yoast SEO Data Analytics DocuSign Google Tag Manager LabVantage Tableau ANS Sigma WordPress.org

+8 more

IQMS Air Atlassian Kinsta Homestead Databricks Pytest Flow

- **Sector:** Pharmaceuticals
- **Industry code:** NAICS 54171, 325414, 333999, SIC 2834
- **Region:** California
- **Revenue:** $82M a year, as listed
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/cellares)

## Pharmaceuticals in United States

Startups like it

- [**ElevateBio** Waltham · founded 2017 *Raised*](https://millionrounds.com/company/elevatebio)
- [**SpectronRx** Indianapolis · founded 2004 *Raised*](https://millionrounds.com/company/spectronrx)
- [**Epirium Bio** San Diego · founded 2008 *Raised*](https://millionrounds.com/company/epirium-bio)
- [**Sollis** GRANDVIEW · founded 2017 *Raised*](https://millionrounds.com/company/sollis)
- [**Castle Creek Pharmaceuticals** Bernards · founded 2015 *Raised*](https://millionrounds.com/company/castle-creek-pharmaceuticals)
- [**Bryn Pharma** Raleigh · founded 2016 *Raised*](https://millionrounds.com/company/bryn-pharma)
- [**AeroSafe Global** Rochester · founded 1995 *Raised*](https://millionrounds.com/company/aerosafe-global)
- [**AZTherapies** Boston · founded 2011 *Raised*](https://millionrounds.com/company/aztherapies)

## Is this your company?

Add your raise, your deck and your story, and put Cellares in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)